FDA Objects To Proximity Of Ferrlecit Reminder And Unbranded Ads
This article was originally published in The Pink Sheet Daily
A reminder ad for the iron therapy on the back cover of a journal and a "belly band" around the issue with similar presentation elements represent a full product ad, FDA's ad division says. Watson makes an unsubstantiated claim for "easy administration."
You may also be interested in...
"Restroom stall cling" for the urinary incontinence drug used at medical meeting gets notice of violation letter from DDMAC.
Pfizer was heavily invested in immuno-oncology combinations five years ago, but following setbacks, the pipeline has shifted considerably, shaped partly by the acquisition of Array.